Does TISLELIZUMAB Cause Off label use? 130 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 130 reports of Off label use have been filed in association with TISLELIZUMAB (TEVIMBRA). This represents 2.6% of all adverse event reports for TISLELIZUMAB.
130
Reports of Off label use with TISLELIZUMAB
2.6%
of all TISLELIZUMAB reports
11
Deaths
51
Hospitalizations
How Dangerous Is Off label use From TISLELIZUMAB?
Of the 130 reports, 11 (8.5%) resulted in death, 51 (39.2%) required hospitalization, and 14 (10.8%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TISLELIZUMAB. However, 130 reports have been filed with the FAERS database.
What Other Side Effects Does TISLELIZUMAB Cause?
Myelosuppression (2,142)
White blood cell count decreased (327)
Neutrophil count decreased (277)
Hepatic function abnormal (221)
Pruritus (213)
Rash (208)
Platelet count decreased (183)
Pyrexia (175)
Nausea (165)
Diarrhoea (145)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TISLELIZUMAB Alternatives Have Lower Off label use Risk?
TISLELIZUMAB vs TISOTUMAB VEDOTIN
TISLELIZUMAB vs TISOTUMAB VEDOTIN-TFTV
TISLELIZUMAB vs TITANIUM DIOXIDE\ZINC
TISLELIZUMAB vs TIVICAY
TISLELIZUMAB vs TIVOZANIB